亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

High-Grade Soft-Tissue Sarcomas: Tumor Response Assessment—Pilot Study to Assess the Correlation between Radiologic and Pathologic Response by Using RECIST and Choi Criteria

医学 实体瘤疗效评价标准 磁共振成像 放射科 软组织 放射治疗 置信区间 化疗 肉瘤 软组织肉瘤 核医学 内科学 进行性疾病 病理
作者
Silvia Stacchiotti,Paola Collini,A. Messina,Carlo Morosi,Marta Barisella,Rossella Bertulli,C. Piovesan,Palma Dileo,Valter Torri,Alessandro Gronchi,Paolo G. Casali
出处
期刊:Radiology [Radiological Society of North America]
卷期号:251 (2): 447-456 被引量:216
标识
DOI:10.1148/radiol.2512081403
摘要

To compare radiologic response as defined according to both Response Evaluation Criteria in Solid Tumors (RECIST) and the new Choi criteria recently proposed for gastrointestinal stromal tumors with pathologic response in high-grade soft-tissue sarcomas (STSs) treated with preoperative chemotherapy and radiation therapy.The institutional ethical committee approved the trial in which patients were enrolled. Signed informed consent was obtained. Thirty-seven patients (21 men, 16 women; mean age, 44.2 years) enrolled in a collaborative randomized trial on preoperative chemotherapy and radiation therapy in localized high-risk STS at a single institution were selected for this retrospective analysis. Tumor response to preoperative treatment was assessed by using both RECIST and Choi criteria at computed tomography (CT) and was adapted to be used at magnetic resonance (MR) imaging. Pathologic response was assessed as either good or very good. Sensitivity, specificity, and predictive value of RECIST and Choi criteria were calculated with pathologic response as the reference standard and were reported with 95% confidence intervals.For 28 patients without synovial sarcomas, sensitivity of RECIST versus adapted Choi criteria was 32.0% versus 88.0% for good response and 41.2% versus 82.4% for very good response, respectively; specificity for pathologic response was 100% versus 100% for not a good response and 90.9% versus 27.3% for not a very good response, respectively. In synovial sarcoma, the nontreatment-related neoplastic cystic component of the tumor was a major obstacle for both RECIST and Choi criteria.In STS treated with chemotherapy and radiation therapy, tumor size may be insufficient to render actual tumor response. Tumor attenuation at CT or tumor contrast material enhancement at MR imaging may complement tumor size, thus making Choi criteria more predictive of pathologic response.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
恸恸完成签到 ,获得积分10
12秒前
George完成签到,获得积分10
25秒前
31秒前
qrj发布了新的文献求助10
36秒前
39秒前
巴山郎完成签到,获得积分10
42秒前
47秒前
林锦都发布了新的文献求助10
54秒前
所所应助孙伟健采纳,获得10
54秒前
Akim应助季生采纳,获得10
1分钟前
情怀应助孙伟健采纳,获得10
1分钟前
1分钟前
1分钟前
1分钟前
孙伟健发布了新的文献求助10
1分钟前
小马甲应助aaa采纳,获得10
1分钟前
1分钟前
淡定的松子完成签到,获得积分10
1分钟前
犹豫的铅笔完成签到,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
aaa发布了新的文献求助10
1分钟前
Sam关闭了Sam文献求助
1分钟前
1分钟前
黄玉发布了新的文献求助10
1分钟前
aaa完成签到,获得积分10
1分钟前
李泷完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
teohsj应助科研通管家采纳,获得10
1分钟前
酷波er应助科研通管家采纳,获得10
1分钟前
1分钟前
Sam发布了新的文献求助10
1分钟前
2分钟前
完美平文完成签到,获得积分10
2分钟前
2分钟前
完美平文发布了新的文献求助10
2分钟前
高分求助中
Cronologia da história de Macau 1600
Treatment response-adapted risk index model for survival prediction and adjuvant chemotherapy selection in nonmetastatic nasopharyngeal carcinoma 1000
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 1000
BRITTLE FRACTURE IN WELDED SHIPS 1000
Intentional optical interference with precision weapons (in Russian) Преднамеренные оптические помехи высокоточному оружию 1000
Atlas of Anatomy 5th original digital 2025的PDF高清电子版(非压缩版,大小约400-600兆,能更大就更好了) 1000
Current concept for improving treatment of prostate cancer based on combination of LH-RH agonists with other agents 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 计算机科学 化学工程 生物化学 物理 复合材料 内科学 催化作用 物理化学 光电子学 细胞生物学 基因 电极 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6187420
求助须知:如何正确求助?哪些是违规求助? 8014765
关于积分的说明 16672471
捐赠科研通 5285472
什么是DOI,文献DOI怎么找? 2817487
邀请新用户注册赠送积分活动 1797074
关于科研通互助平台的介绍 1661272